MedTrace Logo

Prevalence of POU4F3 and SLC17A8 Mutations

NCT01802190 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-07-21

No results posted yet for this study

Summary

The study will allow to identify the prevalence of the SLC17A8 gene mutations in patients suffering from deafness. This phenotype also corresponds to DFNA15 deafness caused by POU4F3 : mutations of this gene will be screened as well.

Conditions

  • Familial Deafness

Interventions

GENETIC

Deafness patients

SLC17A8 et POU4F3 mutations genes analysis on blood samples of deafness patients.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Michel MONDAIN, PU-PH · CHRU Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01802190 on ClinicalTrials.gov